Skip to:

NEWS

Jul 7 | Great news for RNA-based cancer vaccines


Very nice data from Sahin et al (Nature, 2017), showing that neo-epitope vaccination works in human subjects with melanoma.

The authors sequenced RNA from tumor biopsies to identify mutations that could serve as HLA-binding neo-epitopes. The resulting RNA-based vaccines were subsequently injected into a lymph node of the patient, and the idea is that dendritic cells will engulf the vaccine, translate the RNA-encoded antigens and present them to T cells.

...read more

Jul 6 | Launch of Bovine IgG ELISpot


With our new Bovine IgG ELISpot kit, you will be able to quantify the number of antibody producing plasma cells from cow. Antibodies are available as separate reagents.

The new kit and antibodies can be found in our webshop.

...read more

"We have used Mabtech ELISPOT antibodies and reagents for several years. The high quality and standard and competitive price will keep us hooked for years to come. Recently we have started working with Fluorospot, which has really helped us move forward and have opened new avenues in our research. As always management and technical staff have all provided impeccable service."
Cecilia Lindestam Arlehamn
Division of Vaccine Discovery
La Jolla Institute for Allergy & Immunology (LJI)
"Mabtech service is highly customer-friendly and efficient. We have been using Mabtech ELISA kits for the past eight years with full satisfaction. Furthermore, I find Mabtech products the best for even developing my in-house ELISA."
Laksiri Gomes
Centre for Dengue Research
University of Sri Jayawardenepura
"Good with online tutorials, easy manuals to follow, good support when trouble shooting."
Pia Larssen
Karolinska Institutet